James Singleton is a Rheumatology/Immunology physician. OpenAlex indexes 6 publications with 402 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
206 W County Line Road
Suite 310
Highlands Ranch, CO 801292359
Telephone
303-788-8355Registry record last updated 21 Apr 2011.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20251 payment
- AbbVie Inc.Program year20233 payments
- Janssen Biotech, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
95.6%TNF inhibitor92.6%Golimumab100%Part B, office-administered≥15 patientsFolate Analog Metabolic Inhibitor2.6%Methotrexate96%Methotrexate Sodium4%Part D<11 patients+ 2 more classes in this area
Musculoskeletal
2%Bisphosphonate1%Zoledronic acid100%Part B, office-administered≥27 patientsXanthine oxidase inhibitor0.7%Allopurinol100%Part D≥24 patients+ 2 more classes in this area
Metabolism & gastrointestinal
1.5%Corticosteroid0.8%Prednisone100%Part D≥45 patientsAntidiarrheal microorganisms0.3%Folic Acid100%Part D≥15 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Induction pain perception after premedication with propofol vs lidocaine: a pilot study.
PubMed
2000 - Association of psychiatric manifestations with antibodies to ribosomal p proteins in systemic lupus erythematosus
The American Journal of Medicine
1991
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”